Who owns Hada Labo?
Hada Labo is owned by Rohto Pharmaceutical (Japan, TSE: 4527).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: ROHTO Well-being Report 2025 (Rohto Pharmaceutical Integrated Report 2025), ROHTO Pharmaceutical Co., Ltd. Last checked .
Key facts
- Current owner
- ROHTO Pharmaceutical Co., Ltd. reported
- Owner HQ
- 🇯🇵 Japan, Osaka
- Origin
- 🇯🇵 Japan
- Founded
- 2004
- Category
- Personal care & beauty › Skin care › Facial skin care
- Parent ticker
- TSE: 4527
- Last verified
- · 3 sources
About Hada Labo
Hada Labo, written HADALABO by its owner, is a skincare brand that Rohto Pharmaceutical launched in Japan in 2004 around hyaluronic acid; the name means skin lab, and its best-known product is the Gokujyun hyaluronic acid lotion. Rohto took it to the rest of Asia in 2008 and launched Hada Labo Tokyo for the United States in 2013. By its 2024 financial year it was sold in more than 60 countries, after entering Turkey, Spain and South Africa that year, and Rohto calls it the core of its global business.
Ownership timeline of Hada Labo
- Current owner Rohto Pharmaceutical [1] reported
Where Hada Labo sits in Rohto Pharmaceutical
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Rohto Pharmaceutical ownership tree →
See the full Rohto Pharmaceutical brand portfolio (4) →
Other brands owned by Rohto Pharmaceutical
Rohto Pharmaceutical controls 4 brands on Brandtree, 3 of them in personal care & beauty.
Also in personal care & beauty
Other brands in facial skin care, and who owns them
The 76 brands in facial skin care on Brandtree belong to 38 owners. The largest is POLA ORBIS, with 6; Rohto Pharmaceutical has 2.
| Brand | Owner | Owner based in |
|---|---|---|
| DECENCIA | POLA ORBIS | 🇯🇵 Japan |
| Clinique | Estée Lauder | 🇺🇸 United States |
| ANYA | Proya | 🇨🇳 China |
| COSRX | Amorepacific | 🇰🇷 South Korea |
| Clé de Peau Beauté | Shiseido | 🇯🇵 Japan |
| Paula's Choice | Unilever | 🇬🇧 United Kingdom |
| ALBION | KOSÉ | 🇯🇵 Japan |
| O HUI | LG H&H | 🇰🇷 South Korea |
About the owner: Rohto Pharmaceutical
Rohto Pharmaceutical is a publicly listed company headquartered in Osaka, Japan, founded in 1899. Brandtree records 4 brands under its control, and it is listed as TSE: 4527.
Rohto Pharmaceutical is an Osaka company founded on 22 February 1899 to sell Ikatsu, a stomach medicine. It launched Rohto Eye Drops in 1909 and holds the largest share of Japan's over-the-counter eye care market. It moved into skincare in 1975 with the Mentholatum range and in 1988 bought the American company that owns that name, The Mentholatum Company, through which it now sells in much of the world; about 40 per cent of its sales are made outside Japan. Its skincare brands include Hada Labo, Melano CC and Skin Aqua, and in 2025 it acquired the Obagi trademarks for Japan, where it had sold that brand since 2001. In the year to March 2026 it had consolidated sales of ¥343.7 billion and 9,292 employees. It is listed on the Prime Market of the Tokyo Stock Exchange.
Rohto Pharmaceutical: full profile, brands and acquisition history →
🇯🇵 Hada Labo and other Japanese brands
Brandtree records a controlling owner for 437 brands that began in Japan. 21 of them (5%) are now controlled by a company headquartered in another country; Hada Labo is not one of them.
Frequently asked questions
Who is the parent company of Hada Labo?
The parent company of Hada Labo is Rohto Pharmaceutical, a publicly listed company headquartered in Japan.
Is Hada Labo Japanese?
Yes. Hada Labo originated in Japan in 2004 and its owner, Rohto Pharmaceutical, is also headquartered in Japan.
Is Hada Labo still owned by Rohto Pharmaceutical?
Yes. As of 2 October 2026, Hada Labo is still owned by Rohto Pharmaceutical. The ownership record was last checked against primary sources on that date.
Sources (3) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] ROHTO Well-being Report 2025 (Rohto Pharmaceutical Integrated Report 2025) — ROHTO Pharmaceutical Co., Ltd., Annual report; retrieved 2 October 2026.
- [2] ロート製薬 — 肌ラボ — ROHTO Pharmaceutical Co., Ltd., Official document; retrieved 2 October 2026.
- [3] Hada Labo Tokyo — The Mentholatum Company, Official document; retrieved 2 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.